Dr. Seth Eberlin, MD

Dr. Eberlin practices at John Muir Medical Center, Walnut Creek in Walnut Creek, California, part of John Muir Health.

Dr. Eberlin's NPI, 1811295819, was assigned on March 1, 2011. Dr. Eberlin graduated from University of Southern California School of Medicine in 2009. Dr. Eberlin holds California license A115740.

Dr. Eberlin's primary practice is John Muir Medical Center, Walnut Creek, at 1601 Ygnacio Valley Rd, Walnut Creek, CA 94598 in Contra Costa County. The practice phone is (925) 939-3000.

Dr. Eberlin's primary practice is John Muir Medical Center, Walnut Creek in Walnut Creek, California, part of John Muir Health. The medical group on file is John Muir Health. Dmand AI also links Dr. Eberlin to 1 more hospital, 2 group practices and clinics, 1 physician office and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Eberlin practices, 5 sites in all. Vendor and product names are available with a free account.

Plastic surgery is Dr. Eberlin's primary specialty in the NPI Registry, under taxonomy code 208200000X. Dr. Eberlin is board certified in plastic surgery by the American Board of Plastic Surgery. Dr. Eberlin is licensed in California.

CMS data shows 29 Medicare services from Dr. Eberlin across 1 procedure code in 2024, for 36 Medicare patients. Medicare paid $1,606 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 36 Medicare patients who saw Dr. Eberlin in 2026. The largest group is 65 to 74, with 12 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 31% are also on Medicaid. Their average risk score is 2.16, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Eberlin's median patient age at 47, with 34% women.

In 2026, Dr. Eberlin wrote 68 Medicare Part D claims for 24 patients. 99% of them were for generic drugs. CMS names the drug for 54 of them, across 3 drugs with 11 or more claims each, at $550 in total drug cost. In 2023, CMS named 38 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Eberlin for performance year 2026, reported as part of a group.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Eberlin, published from 2013 to 2016. 2014 was the busiest year, with 2. Dr. Eberlin's most frequent co-authors are Jay Calvert, MD, Diya H. Tantawi, FACS, MD and Luis Humberto Macias, MD.

CMS Open Payments shows 85 general payments to Dr. Eberlin from 18 drug and device companies from 2016 to 2025. Gifts make up the largest share, 43% of the total. Allergan Inc. paid the most, $7,181.

Dmand AI lists 6 awards for Dr. Eberlin, most recently Dean's Recognition For Clinical/Academic Achievement in 2008.

Dr. Eberlin graduated from University of Southern California School of Medicine in 2009.

Dr. Eberlin is in network with 1 carrier, including CMS Medicare. Medicare plans come from the most carriers, 1. Check the plan with the practice before a visit.